Early multi-omic signatures and machine learning models predict cardiomyocyte differentiation efficiency and enable robust hPSC differentiation to cardiomyocytes
RNA-seq (gene expression) · human · 80 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 80 samples: 21 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Early multi-omic signatures and machine learning models predict cardiomyocyte differentiation efficiency and enable robust hPSC differentiation to cardiomyocytesbioRxiv : the preprint server for biology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE314132_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1390140 and SRA study SRP656011. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 79 samples.
How we read this: 21 replicated groups read from 80 sample titles; they account for 79 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9382247 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D0, Well Replicate 1 WTC11 hiPSC, Passage 52…
- GSM9382248 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D0, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382249 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D0, Well Replicate 3 WTC11 hiPSC, Passage 52…
- GSM9382250 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D0, Well Replicate 4 WTC11 hiPSC, Passage 52…
- GSM9382251 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D2, Well Replicate 1 WTC11 hiPSC, Passage 52…
- GSM9382252 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D2, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382253 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D2, Well Replicate 3 WTC11 hiPSC, Passage 52…
- GSM9382254 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D2, Well Replicate 4 WTC11 hiPSC, Passage 52…
- GSM9382255 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D4, Well Replicate 1 WTC11 hiPSC, Passage 52…
- GSM9382256 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D4, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382257 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D4, Well Replicate 3 WTC11 hiPSC, Passage 52…
- GSM9382258 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D4, Well Replicate 4 WTC11 hiPSC, Passage 52…
- GSM9382259 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D6, Well Replicate 1 WTC11 hiPSC, Passage 52…
- GSM9382260 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D6, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382261 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D6, Well Replicate 3 WTC11 hiPSC, Passage 52…
- GSM9382262 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D6, Well Replicate 4 WTC11 hiPSC, Passage 52…
- GSM9382263 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D8, Well Replicate 1 WTC11 hiPSC, Passage 52…
- GSM9382264 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D8, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382265 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D8, Well Replicate 4 WTC11 hiPSC, Passage 52…
- GSM9382266 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D10, Well Replicate 2
- GSM9382267 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D13, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382268 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D13, Well Replicate 3 WTC11 hiPSC, Passage 52…
- GSM9382269 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D16, Well Replicate 1 WTC11 hiPSC, Passage 52…
- GSM9382270 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D16, Well Replicate 2 WTC11 hiPSC, Passage 52…
- GSM9382271 WTC11 hiPSC, Passage 52, high purity hPSM-CM differentiation, D16, Well Replicate 3 WTC11 hiPSC, Passage 52…
- GSM9382272 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D0, Well Replicate 1 WTC11 hiPSC, Passage 69…
- GSM9382273 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D0, Well Replicate 2 WTC11 hiPSC, Passage 69…
- GSM9382274 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D0, Well Replicate 3 WTC11 hiPSC, Passage 69…
- GSM9382275 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D0, Well Replicate 4 WTC11 hiPSC, Passage 69…
- GSM9382276 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D2, Well Replicate 1 WTC11 hiPSC, Passage 69…
- GSM9382277 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D2, Well Replicate 2 WTC11 hiPSC, Passage 69…
- GSM9382278 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D2, Well Replicate 3 WTC11 hiPSC, Passage 69…
- GSM9382279 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D2, Well Replicate 4 WTC11 hiPSC, Passage 69…
- GSM9382280 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D4, Well Replicate 1 WTC11 hiPSC, Passage 69…
- GSM9382281 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D4, Well Replicate 2 WTC11 hiPSC, Passage 69…
- GSM9382282 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D4, Well Replicate 3 WTC11 hiPSC, Passage 69…
- GSM9382283 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D4, Well Replicate 4 WTC11 hiPSC, Passage 69…
- GSM9382284 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D6, Well Replicate 1 WTC11 hiPSC, Passage 69…
- GSM9382285 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D6, Well Replicate 2 WTC11 hiPSC, Passage 69…
- GSM9382286 WTC11 hiPSC, Passage 69, low purity hPSM-CM differentiation, D6, Well Replicate 3 WTC11 hiPSC, Passage 69…
+ 40 more — browse all 80 samples with per-sample file links →
- GSE309430 Blood-Based Gene Signatures Associated with Therapeutic Response to Anti-TNF Therapy in Rheumatoid Arthritis: A Combined Meta-Analytical and Machine Learning Approach 8 samples shares signatures, learning, machine
- GSE262419 Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes 4558 samples shares cardiomyocytes, cardiomyocyte
- GSE271689 Enhancing Immunotherapy Outcomes: Spatial Multi-Omics Predictive Models for Non-Small Cell Lung Cancer 586 samples shares multi-omic, predict
- GSE264120 Trastuzumab-associated cardiotoxicity in Patient Specific iPSC-derived cardiomyocytes from HER2+ breast cancer patients 74 samples shares cardiomyocytes, cardiomyocyte
- GSE325674 Leveraging experimental evolution to extract predictive collateral drug response signatures in Ewings Sarcoma 73 samples shares signatures, predict
- GSE263448 Multi-omic signatures of sarcoidosis and progression in bronchoalveolar lavage cells 46 samples shares multi-omic, signatures
- GSE273848 Definition of a multi-omics signature for Esophageal Adenocarcinoma prognosis prediction [totalRNA-seq] 40 samples shares multi-omic, predict
- GSE327944 Effects of adenovirus mediated GLA expression on gene expression of hiPSC-derived ventricular cardiomyocytes from control and Fabri Disease Lines 12 samples shares cardiomyocytes, cardiomyocyte
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.